1028634-75-4 Usage
Uses
Used in Pharmaceutical Industry:
C44H56N6O7 is used as a pharmaceutical compound for its potential biological activity. Its molecular structure, including functional groups and chemical bonds, may contribute to its therapeutic effects and interactions with biological targets.
Used in Biotechnology Industry:
In biotechnology, C44H56N6O7 is used as a component in various applications, such as in the development of new drugs, diagnostic tools, or therapeutic agents. Its complex molecular structure and potential reactivity with other substances make it a promising candidate for further exploration and utilization in this field.
Used in Materials Science:
C44H56N6O7 is utilized in materials science for its potential to form new materials with unique properties. Its molecular structure and chemical bonds could be harnessed to create innovative materials with applications in various industries, such as electronics, energy, or environmental protection.
Further analysis and experimentation are required to fully understand the potential uses and effects of C44H56N6O7, as its specific properties and applications would depend on its molecular structure and interactions with other substances.
Check Digit Verification of cas no
The CAS Registry Mumber 1028634-75-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,8,6,3 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1028634-75:
(9*1)+(8*0)+(7*2)+(6*8)+(5*6)+(4*3)+(3*4)+(2*7)+(1*5)=144
144 % 10 = 4
So 1028634-75-4 is a valid CAS Registry Number.
1028634-75-4Relevant academic research and scientific papers
Process for the preparation of atazanavir
-
Page/Page column 7, (2008/12/06)
The invention relates to a process for the preparation of Atazanavir, which comprises reacting the hydrochloride salt of compound (6) with N-methoxycaxbonyl-L-tert-leucine, the removal of the benzyloxycarbonyl group and the reaction with methoxycarbonyl chloride. The process is particularly advantageous in that it allows to use reduced amounts of N-methoxycarbonyl-L-tert-leucine and avoids the use of unstable intermediates.
